NeuRizer Ltd (ASX: $NRZ) has requested a voluntary suspension from quotation of its ordinary securities on the Australian Securities Exchange (ASX) under Listing Rule 17.2. The suspension is pending the release of an announcement regarding an ASX Price Query Letter and Response, and an announcement in relation to a material acquisition.
The voluntary suspension from quotation has been requested to manage the company's continuous disclosure obligations as it prepares to update the market regarding an ASX Price Query Letter and Response, along with an announcement in relation to a material acquisition.
NeuRizer Ltd (ASX: $NRZ) has voluntarily suspended its ordinary securities from quotation on the ASX to manage its continuous disclosure obligations. The suspension is pending the release of an announcement regarding an ASX Price Query Letter and Response, and an announcement in relation to a material acquisition. The company has requested the voluntary suspension to continue until the earlier of the release of the announcement or the commencement of trading on Thursday 20 June 2024. NeuRizer Ltd states that it is not aware of any reason why the voluntary suspension should not be granted, nor of any other information necessary to inform the market about the voluntary suspension.